Brain cells can now be switched on and off with flashes of light

Decades of tools for mapping and measuring neurons have culminated in optogenetics, a molecular technique that uses light to steer neural circuits with millisecond precision.

Inside a single cubic millimetre of brain tissue, an area no larger than a poppy seed, tens of thousands of neurons and support cells sit tightly packed together, constantly exchanging signals.¹ For more than a century, understanding what that dense thicket actually does required taking it apart in static slices under glass or listening to its collective hum from the outside. Knowing how thoughts, motor commands or sensory impressions arise requires something far more demanding: the ability to reach into a living circuit, activate or quiet a single class of cells, and observe what changes in real time.

That progression from looking at brain structures to recording their electrical signals and ultimately taking direct physical control of them defines modern neurobiology. The culmination of that effort is optogenetics, a method that uses specific colours of light to dictate neuronal activity millisecond by millisecond.¹² In recognition of that capability, the researchers whose foundational work established the technique were awarded the 2026 Nobel Prize in Physiology or Medicine.¹

To understand why optical manipulation represents such a distinct shift, consider the sequence of events that governs communication in the brain. A neuron receives chemical inputs from its neighbours through specialized contact points called synapses. If those incoming signals push the cell beyond a specific electrical threshold, the neuron fires an action potential, a brief electrical spike that travels down its axon. When that spike reaches the far end of the cell, it prompts the release of chemical neurotransmitters that excite or inhibit the next cells in line. Measuring these events can identify which circuits correlate with an action, but proving what a circuit actually causes requires turning those electrical spikes on or off at will.

How did neuroscience move from observing brain cells to manipulating them?

Neuroscience progressed toward direct control by first inventing ways to render individual cells visible and then devising probes to track their electrical conversations. In the late 1800s, the Italian scientist Camillo Golgi developed a tissue-staining technique using silver salts that made individual nerve cells visible under a microscope.¹ Using that method, the Spanish neuroscientist and artist Santiago Ramon y Cajal examined stained brain tissue, producing detailed hand-drawn illustrations of distinct nerve cells and proposing that neurons influence one another across physical junctions. That foundational work on the structural organization of nervous systems earned Golgi and Cajal the 1906 Nobel Prize in Physiology or Medicine.¹

Subsequent generations expanded that visual foundation into dynamic maps of connectivity. During the 1970s, researchers introduced anterograde and retrograde tracing techniques, applying chemical dyes to track the directional wiring connecting distant neural regions.¹ Modern laboratories carry that mapping further through electron microscopy, which directs beams of electrons at biological samples to resolve structures at atomic resolution, and expansion microscopy, which embeds tissue within water-absorbent polymer gels similar to those used in baby diapers to physically enlarge specimens before imaging.¹ Combined with machine learning algorithms, these methods constitute connectomics, the discipline dedicated to charting every physical connection across neural networks. Complementing these microscopic maps, functional magnetic resonance imaging measures blood flow across the whole brain to eavesdrop on active regions noninvasively, an advance built on the fast imaging sequences and spatial encoding techniques recognized with the 2003 Nobel Prize in Physiology or Medicine.¹

Mapping cellular anatomy, however, could not reveal the fast electrical language that neurons speak. The British researchers Alan Hodgkin and Andrew Huxley solved that problem by capturing and measuring the tiny voltage fluctuations that make up action potentials, an achievement honoured with the 1963 Nobel Prize in Physiology or Medicine.¹ Today, multi-electrode arrays can record the electrical discharges of hundreds of neurons simultaneously across separate brain structures.¹ That expanded recording capacity has fundamentally revised assumptions about how networks operate: a series of studies published in 2025 demonstrated that during decision-making tasks in animal subjects, roughly 95% of the brain is actively engaged in the process, rather than activity remaining confined to traditional decision centres.¹

How does light switch individual neurons on and off?

Optogenetics directs neural firing by introducing genes for light-sensitive proteins into specific cells, allowing targeted optical pulses to trigger or halt electrical spikes without disturbing surrounding tissue. Earlier attempts to manipulate living circuits relied on physical hardware. In the late 1980s, the French neurosurgeon Alim-Louis Benabid developed deep brain stimulation, an intervention that implants electrical electrodes into specific brain regions to calm the motor symptoms of Parkinson's disease.¹ Deep brain stimulation functions much like a pacemaker for neural activity and is currently being evaluated to treat severe psychiatric conditions such as obsessive-compulsive disorder, major depression and binge eating.¹ Yet electrical stimulation remains a comparatively blunt instrument because an energized electrode tip indiscriminately stimulates every cell body and passing axon nearby.¹

Optogenetics overcomes that spatial blur by pairing optical physics with molecular genetics. Mammalian nerve cells do not naturally react to visible light, so researchers use benign viral vectors, such as modified lentiviruses, to deliver genetic blueprints directly into target neurons.¹² In foundational work by Edward Boyden and colleagues, scientists adapted Channelrhodopsin-2, a light-sensitive ion channel protein found naturally in green algae.² When illuminated by high-speed optical pulses, these engineered channel proteins open rapidly to admit positively charged ions across the cell membrane.² This influx depolarizes the membrane and prompts an action potential on a millisecond timescale, mimicking normal neural firing.²¹

A related approach operates through chemical locks rather than light beams. Known as designer receptors exclusively activated by designer drugs, or DREADDs, this technique similarly uses benign viral carriers to alter neuronal cell surfaces. Instead of responding to optical wavelengths, the engineered receptors respond exclusively to synthetic drug molecules that otherwise have no effect in the body, providing targeted control over distinct anatomical circuits.¹

What obstacles remain before light therapy can treat human disease?

Translating optogenetics into standard clinical therapy requires overcoming substantial delivery hurdles, including the need to introduce foreign genetic material safely into the human brain and deliver light through opaque neural tissue. Because the technique relies on genetic modification via viral vectors, researchers must verify that viral delivery triggers no harmful immune response and maintains stable expression over many years. Furthermore, visible light scatters rapidly in dense brain tissue, meaning that activating structures deep below the cortex often requires surgically implanted optical fibres or miniaturized light-emitting devices.

These experimental systems represent laboratory tools rather than immediate clinical cures. The animal experiments that demonstrate precise behavioural control rely on genetically modified strains and invasive optical implants that cannot be replicated directly in human patients without extensive regulatory and safety testing. While early clinical investigations are exploring optogenetic interventions to restore functional sight in degenerate retinas and trials for DREADD systems are examining applications in neuropathic pain, Parkinson's disease and epilepsy, broad neurological deployment remains an ongoing experimental objective.

If these delivery and safety barriers are resolved, the clinical implications could be profound. Clinicians could potentially suppress epileptic seizures before symptoms cascade across the cortex, quiet the abnormal circuit oscillations that generate chronic pain, or selectively re-engage degenerating circuits in motor disorders. For researchers, having the ability to toggle individual neuronal populations with light transforms the brain from an inaccessible knot of cells into a responsive system where cause and effect can finally be mapped step by step.

What this rests on

19 sentences trace to 2 sources.

All 2Documents 1Records 0Reporting 1People 0

1. 1 KD Kimberlee D'Ardenne Document · zmescience.com · 7 Oct 2026 The 2026 Nobel Prize in Physiology Went to a Technique That Lets Scientists Control the Brain With Light See the source
2. 2 M media.mit.edu Third-party reporting · media.mit.edu Millisecond-timescale, genetically-targeted optical control of neural activity – MIT Media Lab See the source